Valassis Professor of Urologic Oncology
Urology
Dr. James E. Montie, MD
|
|
Give Review
James Montie practices Urology. He studied medicine at University of Michigan Medical School. He received awards:"CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". James E. Montie is also published. He has 97 publications published. The lastest publication: "Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.'
Publications
- Variation in the use of postoperative radiotherapy among high-risk patients following radical Prostatectomy.
- Notable Outcomes and Trackable Events after Surgery (NOTES): Evaluating an uncomplicated recovery after radical Prostatectomy.
- Preparing Patients and Partners for the Recovery From the Side-Effects of Prostate Cancer Surgery: a Group Approach.
- Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy.
- Understanding the Performance of Active Surveillance Selection Criteria in Diverse Urology Practices.
- Assessment of long-term outcomes associated with urinary prostate Cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
- Prostate capsule sparing versus nerve sparing radical cystectomy for Bladder cancer: results of a randomized, controlled trial.
- Quality of life and satisfaction among prostate Cancer patients followed in a dedicated survivorship clinic.
- What Couples Say about Their Recovery of Sexual Intimacy after Prostatectomy: Toward the Development of a Conceptual Model of Couples' Sexual Recovery after Surgery fo...
- Toward Better Use of Bone Scans Among Men With Early-stage Prostate Cancer.
- Michigan Urological Surgery Improvement Collaborative: Patterns of Care in the Radiographic Staging of Men with Newly Diagnosed Low Risk Prostate Cancer.
- Clinical Predictors and Recommendations for Staging Computed Tomography Scan Among Men With Prostate Cancer.
- Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer.
- Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer.
- Exploring the role of the partner in couples' sexual recovery after surgery for prostate Cancer.
- Improvement in Clinical TNM Staging Documentation Within a Prostate Cancer Quality Improvement Collaborative.
- Variation in prostate Cancer detection rates in a statewide quality improvement collaborative.
- Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive Bladder cancer.
- Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a lar...
- Open surgical partial nephrectomy for upper Tract urothelial carcinoma.
- The Prevalence of the HOXB13 G84E Prostate Cancer Risk Allele in Men Treated with Radical Prostatectomy.
- A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the Bladder.
- Use of advanced treatment technologies among men at low risk of dying from prostate Cancer.
- Evidence of perineural invasion on Prostate biopsy specimen and survival after radical Prostatectomy.
- Certificate of need legislation and the dissemination of robotic surgery for prostate Cancer.
- Understanding the use of immediate intravesical chemotherapy for patients with Bladder cancer.
- Managed Care and the Diffusion of Intensity-modulated Radiotherapy for Prostate Cancer.
- Urethral Cancer.
- Certificate of Need Regulations and the Diffusion of Intensity-modulated Radiotherapy.
- Comparative Effectiveness of External-Beam Radiation Approaches for Prostate Cancer.
- Germline mutations in HOXB13 and prostate-Cancer risk.
- Risk Factors and Quality of Life for Post-Prostatectomy Vesicourethral Anastomotic Stenoses.
- Use of Restaging Bladder Tumor Resection for Bladder Cancer Among Medicare Beneficiaries.
- Identifying Better Practices for Early-stage Bladder Cancer.
- Regional collaboration to improve radiographic staging practices among men with early stage prostate Cancer.
- Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical Prostatectomy.
- Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive Bladder cancer: A multidisciplinary approach.
- Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical Cystectomy for urothelial carcinom...
- Re: effect of a minimum lymph node policy in radical Cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and s...
- Re: a new multimodality technique accurately maps the primary lymphatic landing sites of the Bladder.
- Re: gemcitabine versus bacille calmette-guérin after initial bacille calmette-guérin failure in non-muscle-invasive Bladder cancer: a multicenter prospective randomize...
- Establishment of a urological surgery quality collaborative.
- Delays in diagnosis and Bladder cancer mortality.
- Incontinent or continent Urinary diversion: how to make the right choice.
- T1 Bladder cancer: advocating early cystectomy to improve oncologic control.
- Bladder cancer in 2010: how far have we come?
- Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized Bladder ...
- Combined-modality therapy with gemcitabine and radiation therapy as a Bladder preservation strategy: long-term results of a phase I trial.
- Provider treatment intensity and outcomes for patients with early-stage Bladder cancer.
- Understanding Bladder cancer death: tumor biology versus physician practice.
- Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the Bladder.
- Lymphovascular invasion of urothelial cancer in matched transurethral Bladder tumor resection and radical cystectomy specimens.
- Screen detected, low volume prostate Cancer: the case for active treatment.
- Improving outcomes after radical Cystectomy.
- The causal role of cigarette smoking in Bladder cancer initiation and progression, and the role of urologists in smoking cessation.
- Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
- Hospital lymph node counts and survival after radical Cystectomy.
- Cancer survivorship: challenges and changing paradigms.
- Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate Cancer.
- Randomized clinical trial of a family intervention for prostate Cancer patients and their spouses.
- Short-term health outcome differences between robotic and conventional radical Prostatectomy.
- Evaluation of the Prostate peripheral zone/capsule in patients undergoing radical cystoProstatectomy: defining risk with Prostate capsule sparing cystectomy.
- Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate Cancer therapy.
- Living with prostate Cancer: patients' and spouses' psychosocial status and quality of life.
- Heterogeneity of TMPRSS2 gene rearrangements in multifocal Prostate adenocarcinoma: molecular evidence for an independent group of diseases.
- Integrative analysis of genomic aberrations associated with prostate Cancer progression.
- Early urinary retention after catheter removal following radical Prostatectomy predicts for future symptomatic urethral stricture formation.
- Adoption of new technology and healthcare quality: surgical margins after robotic Prostatectomy.
- Early-stage Bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.
- Measuring health-related quality of life outcomes in Bladder cancer patients using the Bladder Cancer Index (BCI).
- Performance status is a predictor of overall survival of elderly patients with muscle invasive Bladder cancer.
- Features of the metabolic syndrome and prostate Cancer in African-American men.
- Treatment of muscle-invasive Bladder cancer: is cystectomy enough?
- Initial therapy with radical prostatectomy for high risk localized prostate Cancer.
- Preoperative and intraoperative risk factors associated with 30-day morbidity following urological surgery: the National Surgical Quality Improvement Program.
- Association between family history of prostate and breast Cancer among African-American men with prostate Cancer.
- Comparing performance of Morbidity and Mortality Conference and National Surgical Quality Improvement Program for detection of complications after urologic surgery.
- The effects of adjusting for case mix on mortality and length of stay following radical Cystectomy.
- Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate Cancer in black men.
- Incidence of initial local therapy among men with lower-risk prostate Cancer in the United States.
- The role of imaging in the surveillance of urologic malignancies.
- Obesity adversely affects health related quality of life before and after radical retropubic Prostatectomy.
- Use of medications or devices for erectile dysfunction among long-term prostate Cancer treatment survivors: potential influence of sexual motivation and/or indifference.
- Aggressive management of elderly patients with muscle-invasive Bladder cancer.
- A common variant associated with prostate Cancer in European and African populations.
- Quality of care and performance-based reimbursement: the contemporary landscape and implications for urologists.
- Risk factors for adverse outcomes after transurethral resection of Bladder tumors.
- Cystectomy delay more than 3 months from initial Bladder cancer diagnosis results in decreased disease specific and overall survival.
- The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the Bladder. A metaanalytic comparison of chemotherapy versus bacill...
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate Cancer.
- Identifying risk factors for potentially avoidable complications following radical Cystectomy.
- The regionalization of radical cystectomy to Specific medical centers.
- Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the Bladder.
- Conservative treatment of invasive Bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long...
- Regionalization of care: centralizing complex surgical procedures.
- Autoantibody signatures in prostate Cancer.
Schools
University Of Michigan Medical School
Virginia Mason Hospital
Cleveland Clin
Meml Sloan Kettering
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Orchiectomy
- Pelvic Exenteration (For: Gynecologic, Urinary, or Colorectal Malignancy)
Conditions Treated
- Bladder Cancer
- Blood in Urine (Hematuria)
- Elevated PSA (Prostate Specific Antigen)
- Enlarged Prostate (BPH)
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna
- Amerigroup (Wellpoint)
- Blue Cross Blue Shield
- CareSource
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Health Alliance
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- NGS CoreSource
- Paramount
- PHP-Physicians Health Plan
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
Memorial Sloan-Kettering Cancer Center -
Cleveland Clinic Foundation -
Virginia Mason Medical Center -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Helpful Reviews
Similar Doctors
|
|
Dr. James M. Dupree IV, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vesna Ivancic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerilyn M. Latini, MD |
|
|
Dr. Edward J. McGuire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas H. Johnson, MD |
|
|
Dr. Cheryl T. Lee, MD |
|
|
Dr. Katy S. Konkle, MD |
|
|
Dr. Jaclyn C. Milose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Duncan R. Morhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Miller, MD |
|
|
Dr. Anne M. Suskind, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan M. Swearingen, MD |